Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients who are primary non-responders or intolerant to infliximab: A real life multi-center experience of compassionate use
2008-01-01 Danese, S; Mocciaro, F; Guidi, L; Scribano, Ml; Comberlato, M; Vangeli, M; Pulitano, R; Manca, A; Armuzzi, A; Malesci, A; Prantera, C; Cottone, M
C-13 urea breath test for predicting resistance to therapy in Helicobacter pylori infection
2000-01-01 Cremonini, F; Zocco, Ma; Armuzzi, A; Bartolozzi, F; Santarelli, L; Ojetti, V; Candelli, M; Gabrielli, M; Nista, E; Canducci, F; Sanz-Torre, E; Cammarota, G; Anti, M; Gasbarrini, G; Gasbarrini, A
Lack of efficacy of a levofloxacin-based dual therapy for H-pylori eradication
2001-01-01 Di Caro, S; Zocco, Ma; Cremonini, F; Armuzzi, A; Candelli, M; Torre, Hs; Nista, Ec; Carloni, E; Gasbarrini, G; Gasbarrini, A
Association between genetic polymorphism in matrix metalloproteinase 2 (MMP-2, gelatinase A) and susceptibility to primary sclerosing cholangitis
2003-01-01 Cullen, Sn; Armuzzi, A; Ahmad, T; Li, Jh; Ling, K; Yang, X; Jewell, Dp; Chapman, Rw
Role of Helicobacter pylori infection in dyspepsia
1998-01-01 Gasbarrini, A; Franceschi, F; Candelli, M; Ojetti, V; De Luca, A; Torre, Es; Gabrielli, M; Canducci, F; Di Campli, C; Massari, I; Cammarota, G; Lippi, Me; Armuzzi, A; Anti, M; Pola, P; Gasbarrini, G
DNA mismatch repair gene mutations in hereditary non polyposis colorectal cancer (HNPCC) and putative HNPCC (P-HNPCC) Italian families
1997-01-01 Anti, M; Genuardi, M; Deleon, Mp; Viel, A; Fornasarig, M; Valenti, A; Iascone, E; Armuzzi, A; Coco, C; Capozzi, E; Leonardi, F; Bellacosa, A; Pedroni, M; Paravatou, M; Pomponi, Mg; Percesepe, A; Roncucci, L; Tamassia, Mg; Benatti, P; Boiocchi, M; Neri, G
Infliximab in the treatment of glucocorticoid-dependent ulcerative colitis: a 54 week randomized methylprednisolone-controlled trial
2005-01-01 Armuzzi, A; Lupascu, A; De Pascalis, B; Fedeli, P; Vincenti, F; Girsbarrini, G; Gasbarrini, A
Hepatic mitochondrial function assessment through C-13-methionine and C-13-sodium octanoate breath tests
1999-01-01 Armuzzi, A; Gasbarrini, A; Zocco, Ma; Cremonini, F; Marcoccia, S; Di Campli, C; Pola, R; Pola, P; Grieco, A; Anti, M; Gasbarrini, G
Assessment of aminopyrine and methacetin 13C-breath tests in HCV-related chronic liver disease
2002-01-01 Candelli, M; Armuzzi, A; Zocco, Ma; Nista, Ec; Bartolozzi, F; Sanz-Torre, E; Grieco, A; Miele, L; Di Campli, C; Gasbarrini, G; Gasbarrini, A
Apoptosis of epithelial cells in Helicobacter pylori associated chronic gastritis
1997-01-01 Anti, M; Armuzzi, A; Iascone, E; Vecchio, Fm; Pignataro, G; Valenti, A; Covino, M; Lippi, Me; Candeloro, L; Pierconti, F; Gasbarrini, A; Gasbarrini, G
Exocrine pancreatic Schirmer's test involvement in primitive Sjogren's syndrome and his correlation to Schirmer's test
2001-01-01 Candelli, M; Manganelli, C; Nista, Ec; Armuzzi, A; Zocco, Ma; Turco, S; Scullica, L; Gasbarrini, G; Gasbarrini, A
Infliximab in the treatment of moderate to severe glucocorticoid dependent ulcerative colitis: A randomized methylprednisolone controlled trial
2004-01-01 Armuzzi, A; Lupascu, A; Fedeli, P; De Pascalis, B; Gasbarriini, G; Gasbarrini, A
Response to Influenza Vaccine a/H1N1 2009 in Patients With Inflammatory Bowel Disease on Anti TNF-Alpha Therapy
2011-01-01 Andrisani, G; Frasca, D; Armuzzi, A; Papa, A; Marzo, M; Felice, C; Mocci, G; Pugliese, D; Vitale, G; De Vitis, I; Rapaccini, Gl; Guidi, L
Delta(CO2)-C-13 excretion and prevalence of gastrointestinal symptoms in subjects evaluated for H-pylori infection through C-13-urea breath test
1999-01-01 Franceschi, F; Armuzzi, A; Maniccia, E; Ojetti, V; Torre, Es; Candelli, M; Gabrielli, M; Danese, S; Canducci, F; Cremonini, F; Carloni, E; Anit, M
The genetic prediction of the clinical response to infliximab in Crohn's disease (CD): A role for polymorphisms in the TNFa and LTA genes?
2002-01-01 De Silva, Ap; Ahmad, T; Vermiere, S; Armuzzi, A; Mulcahy-Hawes, K; Travis, S; Welsh, K; Rutgeerts, P; Jewell, D
Impact or lactobacillus GG supplementation on anti-H-pylori therapy-related side effects: A randomized placebo-controlled study
2000-01-01 Cremonini, F; Armuzzi, A; Gabrielli, M; Bartolozzi, F; Candelli, M; Canducci, F; Ojetti, V; Zocco, Ma; Santarelli, L; Padalino, C; Anti, M; Gasbarrini, G; Gasbarrini, A
Family history of peptic ulcer and a positive C-13 urea breath test are predictive of gastroduodenal ulcer disease in uninvestigated dyspeptic patients
1998-01-01 Armuzzi, A; Anti, M; Catananti, C; Lippi, Me; Covino, M; Cipriani, S; Valenti, A; Gasbarrini, A; Gasbarrini, G
C-13 urea breath test for predicting resistance to therapy in Helicobacter pylori infection
2001-01-01 Cremonini, F; Zocco, Ma; Armuzzi, A; Bartolozzi, F; Di Caro, S; Santarelli, L; Santarelli, A; Gabrielli, M; Gasbarrini, G; Gasbarrini, A
Aminopyrine and methacetin 13C-breath tests to assess hepatic function in HCV-related chronic liver disease
2004-01-01 Nista, Ec; Cazzato, Ia; Armuzzi, A; Fini, L; Candelli, M; Zocco, Ma; Dal Verme, Lz; Finizio, R; Gasbarrini, G; Gasbarrini, A
H-pylori gastric infection and rheumatic diseases
1999-01-01 Danese, S; Gasbarrini, A; Zoli, A; Franceschi, F; D'Agostino, Ma; Candelli, M; Armuzzi, A; Gabrielli, M; Ojetti, V; Torre, Es; Canducci, F; Cremonini, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Successful induction of clinical response and remission with certolizumab pegol in Crohn's disease patients who are primary non-responders or intolerant to infliximab: A real life multi-center experience of compassionate use | 1-gen-2008 | Danese, S; Mocciaro, F; Guidi, L; Scribano, Ml; Comberlato, M; Vangeli, M; Pulitano, R; Manca, A; Armuzzi, A; Malesci, A; Prantera, C; Cottone, M | |
| C-13 urea breath test for predicting resistance to therapy in Helicobacter pylori infection | 1-gen-2000 | Cremonini, F; Zocco, Ma; Armuzzi, A; Bartolozzi, F; Santarelli, L; Ojetti, V; Candelli, M; Gabrielli, M; Nista, E; Canducci, F; Sanz-Torre, E; Cammarota, G; Anti, M; Gasbarrini, G; Gasbarrini, A | |
| Lack of efficacy of a levofloxacin-based dual therapy for H-pylori eradication | 1-gen-2001 | Di Caro, S; Zocco, Ma; Cremonini, F; Armuzzi, A; Candelli, M; Torre, Hs; Nista, Ec; Carloni, E; Gasbarrini, G; Gasbarrini, A | |
| Association between genetic polymorphism in matrix metalloproteinase 2 (MMP-2, gelatinase A) and susceptibility to primary sclerosing cholangitis | 1-gen-2003 | Cullen, Sn; Armuzzi, A; Ahmad, T; Li, Jh; Ling, K; Yang, X; Jewell, Dp; Chapman, Rw | |
| Role of Helicobacter pylori infection in dyspepsia | 1-gen-1998 | Gasbarrini, A; Franceschi, F; Candelli, M; Ojetti, V; De Luca, A; Torre, Es; Gabrielli, M; Canducci, F; Di Campli, C; Massari, I; Cammarota, G; Lippi, Me; Armuzzi, A; Anti, M; Pola, P; Gasbarrini, G | |
| DNA mismatch repair gene mutations in hereditary non polyposis colorectal cancer (HNPCC) and putative HNPCC (P-HNPCC) Italian families | 1-gen-1997 | Anti, M; Genuardi, M; Deleon, Mp; Viel, A; Fornasarig, M; Valenti, A; Iascone, E; Armuzzi, A; Coco, C; Capozzi, E; Leonardi, F; Bellacosa, A; Pedroni, M; Paravatou, M; Pomponi, Mg; Percesepe, A; Roncucci, L; Tamassia, Mg; Benatti, P; Boiocchi, M; Neri, G | |
| Infliximab in the treatment of glucocorticoid-dependent ulcerative colitis: a 54 week randomized methylprednisolone-controlled trial | 1-gen-2005 | Armuzzi, A; Lupascu, A; De Pascalis, B; Fedeli, P; Vincenti, F; Girsbarrini, G; Gasbarrini, A | |
| Hepatic mitochondrial function assessment through C-13-methionine and C-13-sodium octanoate breath tests | 1-gen-1999 | Armuzzi, A; Gasbarrini, A; Zocco, Ma; Cremonini, F; Marcoccia, S; Di Campli, C; Pola, R; Pola, P; Grieco, A; Anti, M; Gasbarrini, G | |
| Assessment of aminopyrine and methacetin 13C-breath tests in HCV-related chronic liver disease | 1-gen-2002 | Candelli, M; Armuzzi, A; Zocco, Ma; Nista, Ec; Bartolozzi, F; Sanz-Torre, E; Grieco, A; Miele, L; Di Campli, C; Gasbarrini, G; Gasbarrini, A | |
| Apoptosis of epithelial cells in Helicobacter pylori associated chronic gastritis | 1-gen-1997 | Anti, M; Armuzzi, A; Iascone, E; Vecchio, Fm; Pignataro, G; Valenti, A; Covino, M; Lippi, Me; Candeloro, L; Pierconti, F; Gasbarrini, A; Gasbarrini, G | |
| Exocrine pancreatic Schirmer's test involvement in primitive Sjogren's syndrome and his correlation to Schirmer's test | 1-gen-2001 | Candelli, M; Manganelli, C; Nista, Ec; Armuzzi, A; Zocco, Ma; Turco, S; Scullica, L; Gasbarrini, G; Gasbarrini, A | |
| Infliximab in the treatment of moderate to severe glucocorticoid dependent ulcerative colitis: A randomized methylprednisolone controlled trial | 1-gen-2004 | Armuzzi, A; Lupascu, A; Fedeli, P; De Pascalis, B; Gasbarriini, G; Gasbarrini, A | |
| Response to Influenza Vaccine a/H1N1 2009 in Patients With Inflammatory Bowel Disease on Anti TNF-Alpha Therapy | 1-gen-2011 | Andrisani, G; Frasca, D; Armuzzi, A; Papa, A; Marzo, M; Felice, C; Mocci, G; Pugliese, D; Vitale, G; De Vitis, I; Rapaccini, Gl; Guidi, L | |
| Delta(CO2)-C-13 excretion and prevalence of gastrointestinal symptoms in subjects evaluated for H-pylori infection through C-13-urea breath test | 1-gen-1999 | Franceschi, F; Armuzzi, A; Maniccia, E; Ojetti, V; Torre, Es; Candelli, M; Gabrielli, M; Danese, S; Canducci, F; Cremonini, F; Carloni, E; Anit, M | |
| The genetic prediction of the clinical response to infliximab in Crohn's disease (CD): A role for polymorphisms in the TNFa and LTA genes? | 1-gen-2002 | De Silva, Ap; Ahmad, T; Vermiere, S; Armuzzi, A; Mulcahy-Hawes, K; Travis, S; Welsh, K; Rutgeerts, P; Jewell, D | |
| Impact or lactobacillus GG supplementation on anti-H-pylori therapy-related side effects: A randomized placebo-controlled study | 1-gen-2000 | Cremonini, F; Armuzzi, A; Gabrielli, M; Bartolozzi, F; Candelli, M; Canducci, F; Ojetti, V; Zocco, Ma; Santarelli, L; Padalino, C; Anti, M; Gasbarrini, G; Gasbarrini, A | |
| Family history of peptic ulcer and a positive C-13 urea breath test are predictive of gastroduodenal ulcer disease in uninvestigated dyspeptic patients | 1-gen-1998 | Armuzzi, A; Anti, M; Catananti, C; Lippi, Me; Covino, M; Cipriani, S; Valenti, A; Gasbarrini, A; Gasbarrini, G | |
| C-13 urea breath test for predicting resistance to therapy in Helicobacter pylori infection | 1-gen-2001 | Cremonini, F; Zocco, Ma; Armuzzi, A; Bartolozzi, F; Di Caro, S; Santarelli, L; Santarelli, A; Gabrielli, M; Gasbarrini, G; Gasbarrini, A | |
| Aminopyrine and methacetin 13C-breath tests to assess hepatic function in HCV-related chronic liver disease | 1-gen-2004 | Nista, Ec; Cazzato, Ia; Armuzzi, A; Fini, L; Candelli, M; Zocco, Ma; Dal Verme, Lz; Finizio, R; Gasbarrini, G; Gasbarrini, A | |
| H-pylori gastric infection and rheumatic diseases | 1-gen-1999 | Danese, S; Gasbarrini, A; Zoli, A; Franceschi, F; D'Agostino, Ma; Candelli, M; Armuzzi, A; Gabrielli, M; Ojetti, V; Torre, Es; Canducci, F; Cremonini, F |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2157
Data di pubblicazione
- 2020 - 2025111
- 2010 - 20191343
- 2000 - 2009591
- 1990 - 1999111
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY123
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...120
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE100
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY59
- ANNALS OF ONCOLOGY57
- JOURNAL OF CLINICAL ONCOLOGY45
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng798
- ita24
- und6
Accesso al fulltext
- no fulltext2104
- reserved51
- open2